Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Enterprise Value (2017 - 2025)

Inspire Medical Systems' Enterprise Value history spans 9 years, with the latest figure at -$308.3 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 30.81% year-over-year to -$308.3 million; the TTM value through Dec 2025 reached -$308.3 million, up 30.81%, while the annual FY2025 figure was -$308.3 million, 30.81% up from the prior year.
  • Enterprise Value for Q4 2025 was -$308.3 million at Inspire Medical Systems, up from -$322.6 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$196.3 million in Q2 2022 and bottomed at -$467.1 million in Q2 2023.
  • The 5-year median for Enterprise Value is -$390.1 million (2024), against an average of -$351.0 million.
  • The largest annual shift saw Enterprise Value tumbled 137.9% in 2023 before it surged 31.56% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$214.5 million in 2021, then crashed by 110.48% to -$451.4 million in 2022, then fell by 1.99% to -$460.4 million in 2023, then increased by 3.22% to -$445.5 million in 2024, then surged by 30.81% to -$308.3 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Enterprise Value are -$308.3 million (Q4 2025), -$322.6 million (Q3 2025), and -$300.9 million (Q2 2025).